Effects of intraperitoneal levobupivacaine on pain after laparoscopic cholecystectomy: A prospective, randomized, double-blinded study

Amaç: İntraperitoneal levobupivakain uygulamasının laparoskopik kolesistektomi sonrası ağrı üzerine etkisinin randomize, çift kör, plasebo-kontrollü çalışma olarak araştırılması amaçlandı. Gereç ve Yöntem: Tüm hastalara trokar giriş yerlerine levobupivakain %0.25’lik (toplam 15 mL) infiltrasyonu ile birlikte, pnömoperiton sonrası, randomizasyon şemasına göre, intraperitoneal olarak hepatodiyafragmatik alana ve safra kesesi üst lojuna toplam 40 mL %0.25’lik levobupivakain (Grup LB, n=20) veya 40 mL normal salin (Grup NS, n=20) uygulandı. İki grubun intraoperatif özellikleri, postoperatif ağrı durumu ve ek analjezik gereksinimi, yan etkiler ve hasta memnuniyeti ilk 24 saatlik dönemde karşılaştırıldı. Bulgular: Postoperatif ağrı skoru, postoperatif ilk 30. dk’da, Grup LB’de Grup NS’ye göre anlamlı olarak daha düşüktü (p

İntraperitoneal levobupivakain uygulamasının laparoskopik kolesistektomi sonrası ağrı üzerine etkisi: Prospektif, randomize, çift-kör çalışma

Objectives: We aimed to determine the effects of intraperitoneal administration of levobupivacaine on pain after laparoscopic cholecystectomy in a prospective, randomized, double-blinded, placebo-controlled trial. Methods: In all patients, infiltration of levobupivacaine 0.25% (15 mL) was used prior to skin incisions for trocar insertion. After pneumoperitoneum was achieved, patients were allocated randomly to receive intraperitoneally either 40 mL of 0.25% levobupivacaine (LB group, n=20) or normal saline (NS group, n=20) under direct vision into the hepatodiaphragmatic lodge and above the gallbladder. Data of intraoperative variables, postoperative pain relief, rescue analgesic consumption, side effects, and patient satisfaction were followed in both groups. Results: The postoperative pain scores were significantly lower in the first half-hour period in the LB group than in the NS group (p<0.05). However, the incidence of right shoulder pain was not significantly different between the LB group (10%) and NS group (15%). The mean dose of meperidine consumption and the number of patients needing rescue meperidine were significantly lower in the LB group than in the NS group (p<0.05). Significantly lower vomiting incidence and increased patient satisfaction were determined in the LB group compared to the NS group (p<0.05). Conclusion: Intraperitoneal administration of 40 mL levobupivacaine 0.25% given immediately after pneumoperitoneum into the hepatodiaphragmatic lodge and above the gallbladder demonstrated useful effects on postoperative pain relief after laparoscopic cholecystectomy, especially in the early postoperative period, and reduced postoperative rescue analgesic requirement, with excellent patient satisfaction. There were no LB-related complications or side effects.

___

  • 1. Lee IO, Kim SH, Kong MH, Lee MK, Kim NS, Choi YS, et al. Pain after laparoscopic cholecystectomy: the ef ect and timing of incisional and intraperitoneal bupivacaine. Can J Anaesth 2001;48(6):545-50.
  • 2. McGinn FP, Miles AJ, Uglow M, Ozmen M, Terzi C, Humby M. Randomized trial of laparoscopic cholecystectomy and minicholecystectomy. Br J Surg 995;82(10):1374-7.
  • 3. Joris J, Thiry E, Paris P, Weerts J, Lamy M. Pain after laparoscopic cholecystectomy: characteristics and ef ect of intraperitoneal bupivacaine. Anesth Analg 1995;81(2):379-84.
  • 4. Berde CB, Strichartz GR. Local anesthetics. In: Miller RD, editor. Anesthesia. 5th ed. Philadelphia PA: Churchill Livingstone; 2000. p. 491-521.
  • 5. Boddy AP, Mehta S, Rhodes M. The ef ect of intraperitoneal local anesthesia in laparoscopic cholecystectomy: a systematic review and meta-analysis. Anesth Analg 2006;103(3):682-8.
  • 6. Gristwood RW. Cardiac and CNS toxicity of levobupivacaine: strengths of evidence for advantage over bupivacaine. Drug Saf 2002;25(3):153-63.
  • 7. Alexander JI. Pain after laparoscopy. Br J Anaesth 1997;79(3):369-78.
  • 8. Mraović B, Majerić-Kogler V. Pain after laparoscopic cholecystectomy. Br J Anaesth 1998;80(3):406-7.
  • 9. Sozbilen M, Yeniay L, Unalp M, Makay O, Pirim A, Ulukaya S, et al. Ef ects of ropivacaine on pain after laparoscopic cholecystectomy: a prospective, randomized study. Adv Ther 2007;24(2):247-57.
  • 10. Szem JW, Hydo L, Barie PS. A double-blinded evaluation of intraperitoneal bupivacaine vs saline for the reduction of postoperative pain and nausea after laparoscopic cholecystectomy. Surg Endosc 1996;10(1):44-8.
  • 11. Pasqualucci A, de Angelis V, Contardo R, Colò F, Terrosu G, Donini A, et al. Preemptive analgesia: intraperitoneal local anesthetic in laparoscopic cholecystectomy. A randomized, double-blind, placebo-controlled study. Anesthesiology 1996;85(1):11-20.
  • 12. Louizos AA, Hadzilia SJ, Leandros E, Kouroukli IK, Georgiou LG, Bramis JP. Postoperative pain relief after laparoscopic cholecystectomy: a placebo-controlled double-blind randomized trial of preincisional ini ltration and intraperitoneal instillation of levobupivacaine 0.25%. Surg Endosc 2005;19(11):1503-6.
  • 13. Ng A, Swami A, Smith G, Robertson G, Lloyd DM. Is intraperitoneal levobupivacaine with epinephrine useful for analgesia following laparoscopic cholecystectomy? A randomized controlled trial. Eur J Anaesthesiol 2004;21(8):653-7.
  • 14. Mouton WG, Bessell JR, Otten KT, Maddern GJ. Pain after laparoscopy. Surg Endosc 1999;13(5):445-8.